Senior Scientist, Chemistry Service
Department of Laboratory Medicine
National Institutes of Medicine
Dr. Steven J Soldin was appointed to the faculty at The Hospital for Sick Children in 1977 and rose to the position of Full Tenured Professor in the Departments of Pharmacology and Clinical Biochemistry at the University of Toronto in 1985. In 1988 he moved to Washington DC to head the Chemistry section at Children’s National Medical Center, a position he held until November 2008.During this time he was a tenured Full Professor in the Department of Pathology at the George Washington University School of Medicine, Washington, DC. From 2002-2011 he directed the Bioanalytical Core Laboratory at Georgetown University where he held the position of Adjunct Full Professor in the Departments of Clinical Endocrinology and Metabolism and Pharmacology. In October 2011 he accepted the position of Senior Scientist in the Department of Laboratory Medicine in the Clinical Center at NIH.
Dr. Soldin currently oversees the mass spectrometry section of the clinical chemistry service and research programs and is also involved in the routine laboratory and postdoctoral training of PhD and MD clinical chemistry fellows. He has served as President of several National organizations including the National Academy of Clinical Biochemistry, the American Board of Clinical Chemistry and the International Association of Therapeutic Drug Monitoring and Clinical Toxicology. He has many patents, has supervised 16 post-graduate students to PhD or MS degrees and served as Editor of the Journal Therapeutic Drug Monitoring, Associate Editor of Clinical Biochemistry and as a member of the editorial board of Clinical Chemistry. He has published 2 textbooks, Pediatric Reference Intervals currently in its 7th edition, and The Biochemical Basis of Pediatric Disease in its 3rd edition. He has to date published 249 papers in peer reviewed journals.
His research interests focus on improving current diagnostic and therapeutic tests in clinical chemistry which include the measurement of steroid and thyroid hormone profiles by tandem mass spectrometry. New foci will include measurement of a neurosteroid profile and assessment of its role in diagnosis and treatment of illnesses such as epilepsy, depressive illnesses, PMS etc. Also measurement of bioactive peptides such as Neuropeptide Y and evaluation of the role of NPY in cardiovascular diseases and oncology.